Mary Coleman

Mary Coleman has extensive experience in investor relations and corporate communications within the pharmaceutical and biotechnology industries. Currently serving as Vice President and Head of Investor Relations at Catalyst Pharmaceuticals, Inc. since 2021, previous roles include Vice President of Investor Relations at BioXcel Therapeutics, Inc. and Vice President and Head of Investor Relations at Jubilant Pharma. Additional experience includes leading investor relations and corporate communications at BioDelivery Sciences International, Agile Therapeutics, and Savient Pharmaceuticals, among others. Mary Coleman began their career in communications at Wolters Kluwer and 3 Dimensional Pharmaceuticals, and holds a Bachelor's degree from Bowling Green State University as well as post-graduate studies from Washington University in St. Louis.